Search Ontology:
ChEBI
LY-2090314
- Term ID
- CHEBI:167661
- Synonyms
-
- 3-[9-fluoro-1,2,3,4-tetrahydro-2-(1-piperidinylcarbonyl)pyrrolo[3,2,1-jk][1,4]benzodiazepin-7-yl]-4-imidazo[1,2-a]pyridin-3-yl-1H-pyrrole-2,5-dione
- 3-[9-fluoro-2-(piperidin-1-ylcarbonyl)-1,2,3,4-tetrahydro[1,4]diazepino[6,7,1-hi]indol-7-yl]-4-(imidazo[1,2-a]pyridin-3-yl)-1H-pyrrole-2,5-dione
- LY 2090314
- LY2090314
- Definition
- A member of the class of diazepinoindoles that is 1,2,3,4-tetrahydro[1,4]diazepino[6,7,1-hi]indole substituted by piperidin-1-ylcarbonyl, 4-(imidazo[1,2-a]pyridin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl and fluoro groups at position 2, 7 and 9, respectively. It is a potent ATP-competitive inhibitor of glycogen synthase kinase-3 (GSK-3) with IC50 values of 1.5 nM and 0.9 nM for GSK-3alpha and GSK-3beta. The drug is in clinical development for the treatment of advanced/metastatic cancer.
- References
-
- CAS:603288-22-8
- Chemspider:8204956
- DrugBank:DB11913
- LINCS:LSM-45915
- PMID:15267232
- PMID:23305709
- PMID:24658455
- PMID:25915038
- PMID:26403509
- PMID:26735141
- PMID:26967552
- PMID:28397338
- PMID:28766886
- PMID:28772167
- PMID:29593255
- PMID:29751783
- PMID:31261037
- PMID:31562256
- PMID:31623866
- PMID:32382110
- PMID:32391602
- PMID:32539133
- Ontology
- ChEBI ( EBI )
- is a type of
- has_role
-
Phenotype
Phenotype resulting from LY-2090314
Phenotype where environments contain LY-2090314
Phenotype modified by environments containing LY-2090314
Human Disease Model